.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.when his patients ask how long they’ll be at the hospital with a procedure like this, he tries to manage their expectations.
.
worried about how helen was doing after doctors performed surgery on her colon the same day he was admitted, robert, whose condition stabilized, had a simple request for his nurse:
.